Analytic validation of a quantitative real-time PCR assay to measure CMV viral load in whole blood

Diagnostic Molecular Pathology

Volumn 16, Issue 2, 2007, Pages 73-80

  Thorne, Leigh B ^a,b   Civalier, Chris ^a   Booker, Jessica ^a   Fan, Hongxin ^a   Gulley, Margaret L ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Antigenemia; CMV; Cytomegalovirus; Viral load

Indexed keywords

APOLIPOPROTEIN B; DNA; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BINDING AFFINITY; BLOOD; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA DETERMINATION; GENE AMPLIFICATION; GENOMICS; HUMAN; INSTRUMENT; MEASUREMENT; MONITORING; POINT MUTATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STRUCTURAL GENE; VALIDATION PROCESS; VIRUS LOAD; AIDS RELATED COMPLEX; CYTOMEGALIC INCLUSION BODY DISEASE; DNA SEQUENCE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; ORGAN TRANSPLANTATION; PREDICTION AND FORECASTING; REFERENCE VALUE; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY; VIROLOGY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; ORGAN TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

EID: 34347405138     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e318033ab9e     Document Type: Article

References (28)

1. Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood. 2003;101:407-414.
2. de la Hoz RE, Stephens G, Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol. 2002;25(suppl 2):S1-S12.
3. Erice A, Tierney C, Hirsch M, et al. Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clin Infect Dis. 2003;37:567-578.
4. Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl. 2005;11:881-890.
5. Sola R, Diaz JM, Guirado L, et al. Significance of cytomegalovirus infection in renal transplantation. Transplant Proc. 2003;35:1753-1755.
6. Sarkio S, Halme L, Arola J, et al. Gastroduodenal cytomegalovirus infection is common in kidney transplantation patients. Scand J Gastroenterol. 2005;40:508-514.
7. Wohl DA, Zeng D, Stewart P, et al. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies. J Acquir Immune Defic Syndr. 2005;38:538-544.
8. Zaia J. Infections in organ transplant recipients. In: Richman D, Whitley R, Hayden F, eds. Clinical Virology. Washington, DC: ASM Press; 2002:79-100.
9. Boeckh M, Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev. 1998;11:533-554.
10. Guiver M, Fox AJ, Mutton K, et al. Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients. Transplantation. 2001;71:1609-1615.
11. Ljungman P, Reusser P, de la Camara R, et al. Management of CMV infections: recommendations from the infectious diseases working party of the EBMT. Bone Marrow Transplant. 2004;33:1075-1081.
12. Meijer E, Boland GJ, Verdonck LF. Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants. Clin Microbiol Rev. 2003;16:647-657.
13. Zamora MR, Davis RD, Leonard C. Management of cytomegalovirus infection in lung transplant recipients: evidence-based recommendations. Transplantation. 2005;80:157-163.
14. Sanchez JL, Storch GA. Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol. 2002;40:2381-2386.
15. Piiparinen H, Helantera I, Lappalainen M, et al. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients. J Med Virol. 2005;76:367-372.
16. Piiparinen H, Hockerstedt K, Gronhagen-Riska C, et al. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J Clin Virol. 2004;30:258-266.
17. Li H, Dummer JS, Estes WR, et al. Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol. 2003;41:187-191.
18. Mengelle C, Sandres-Saune K, Pasquier C, et al. Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J Clin Microbiol. 2003;41:3840-3845.
19. Huang ES, Chen ST, Pagano JS. Human cytomegalovirus. Purification and characterization of viral DNA. J Virol. 1973;12:1473-1481.
20. Greenlee DJ, Fan H, Lawless K, et al. Quantitation of CMV by real-time PCR in transfusable RBC units. Transfusion. 2002;42:403-408.
21. Boivin G, Belanger R, Delage R, et al. Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation. J Clin Microbiol. 2000;38:4356-4360.
22. Boeckh M, Gallez-Hawkins GM, Myerson D, et al. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation. 1997;64:108-113.
23. Nitsche A, Steuer N, Schmidt CA, et al. Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol. 2000;38:2734-2737.
24. Razonable RR, Brown RA, Wilson J, et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation. 2002;73:968-973.
25. Schafer P, Tenschert W, Schroter M, et al. False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation. J Clin Microbiol. 2000;8:3249-3253.
26. Zipeto D, Morris S, Hong C, et al. Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes. J Clin Microbiol. 1995;33:2607-2611.
27. Tanaka N, Kimura H, Iida K, et al. Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol. 2000;60:455-462.
28. Chou S, Lurain NS, Thompson KD, et al. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus. J Infect Dis. 2003;188:32-39.